SMITH CHAS P & ASSOCIATES PA CPAS
Position in BMY — Bristol Myers Squibb Co
CIK 1082509
LAKELAND, FL
Position in BMY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$425,944
+$118,433 QoQ
Shares Held
7,023
+23.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SMITH CHAS P & ASSOCIATES PA CPAS holds $179,997,284 across 8 Drug Manufacturers - General names. BMY ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
251,939 | $61,583,969 | |
| 2 | MRK |
Merck & Co., Inc.
|
367,523 | $44,209,341 | |
| 3 | AMGN |
Amgen Inc
|
118,985 | $41,864,872 | |
| 4 | NVO |
Novo Nordisk A S
|
801,586 | $29,458,285 | |
| 5 | LLY |
ELI LILLY & Co
|
1,254 | $1,153,391 | |
| 6 | ABBV |
AbbVie Inc.
|
4,249 | $924,115 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
7,023 | $425,944 | |
| 8 | PFE |
Pfizer Inc
|
13,439 | $377,367 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $425,944 | 7,023 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $307,511 | 5,701 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $204,799 | 4,541 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $298,755 | 6,454 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $419,245 | 6,874 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $413,510 | 7,311 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $511,242 | 9,881 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $410,399 | 9,882 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $539,859 | 9,955 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $362,710 | 7,069 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $333,962 | 5,754 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $550,865 | 8,614 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $545,400 | 7,869 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $631,433 | 8,776 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $616,705 | 8,675 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $381,843 | 4,959 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $363,543 | 4,978 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $314,867 | 5,050 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $294,134 | 4,971 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $336,171 | 5,031 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $319,311 | 5,058 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $313,747 | 5,058 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $306,454 | 5,083 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $313,286 | 5,328 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $296,982 | 5,328 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||